Free Trial

Calumet Specialty Products Partners (NASDAQ:CLMT) Posts Earnings Results

Calumet Specialty Products Partners logo with Oils/Energy background
Remove Ads

Calumet Specialty Products Partners (NASDAQ:CLMT - Get Free Report) released its quarterly earnings results on Friday. The oil and gas company reported ($0.47) earnings per share for the quarter, beating analysts' consensus estimates of ($1.06) by $0.59, Zacks reports. The firm had revenue of $949.50 million for the quarter, compared to analysts' expectations of $921.76 million. During the same quarter in the previous year, the business earned ($0.59) EPS. The company's revenue for the quarter was down 2.8% on a year-over-year basis.

Calumet Specialty Products Partners Price Performance

CLMT traded down $0.42 during midday trading on Tuesday, reaching $13.04. 2,723,281 shares of the company's stock traded hands, compared to its average volume of 1,469,918. The firm has a fifty day moving average of $17.98 and a two-hundred day moving average of $19.22. The stock has a market capitalization of $1.12 billion, a price-to-earnings ratio of -4.72 and a beta of 1.88. Calumet Specialty Products Partners has a 52 week low of $9.97 and a 52 week high of $25.29.

Insider Buying and Selling at Calumet Specialty Products Partners

In other Calumet Specialty Products Partners news, Director Jennifer Straumins sold 37,861 shares of the company's stock in a transaction that occurred on Wednesday, December 18th. The stock was sold at an average price of $21.42, for a total transaction of $810,982.62. Following the completion of the transaction, the director now owns 1,184,589 shares of the company's stock, valued at $25,373,896.38. This represents a 3.10 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. 2.91% of the stock is currently owned by corporate insiders.

Remove Ads

Analyst Upgrades and Downgrades

Several research analysts have recently commented on the company. HC Wainwright reiterated a "buy" rating and issued a $33.00 price objective on shares of Calumet Specialty Products Partners in a report on Monday. UBS Group downgraded Calumet Specialty Products Partners from a "neutral" rating to a "sell" rating and decreased their price objective for the stock from $20.50 to $15.00 in a report on Tuesday, February 4th. StockNews.com upgraded Calumet Specialty Products Partners to a "sell" rating in a report on Monday, November 18th. Finally, TD Cowen downgraded Calumet Specialty Products Partners from a "buy" rating to a "hold" rating and decreased their price objective for the stock from $26.00 to $16.00 in a report on Tuesday. Two analysts have rated the stock with a sell rating, one has issued a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat, Calumet Specialty Products Partners currently has an average rating of "Hold" and an average price target of $21.60.

Get Our Latest Research Report on Calumet Specialty Products Partners

Calumet Specialty Products Partners Company Profile

(Get Free Report)

Calumet, Inc engages in the manufacturing, formulating, and marketing of a diversified slate of specialty branded products and renewable fuels to customers across a broad range of consumer-facing and industrial markets. It operates through the following segments: Specialty Products & Solutions, Performance Brands, Montana/Renewables, and Corporate.

Featured Articles

Earnings History for Calumet Specialty Products Partners (NASDAQ:CLMT)

Should You Invest $1,000 in Calumet Specialty Products Partners Right Now?

Before you consider Calumet Specialty Products Partners, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Calumet Specialty Products Partners wasn't on the list.

While Calumet Specialty Products Partners currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Best ETFs for Spring 2025: Strong and Steady Investing
Is There Still Money in AI? How to Invest in the Next Big Wave
AMD at Rock Bottom? Analysts Predict a MAJOR Rebound!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads